TG Therapeutics Inc (TGTX)

Days of sales outstanding (DSO)

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Receivables turnover		2.51	4.33	—	4.82	—
DSO	days	145.35	84.37	—	75.79	—

December 31, 2024 calculation

DSO = 365 ÷ Receivables turnover
= 365 ÷ 2.51
= 145.35

Based on the provided data, TG Therapeutics Inc's days of sales outstanding (DSO) has shown some fluctuations over the years:

1. As of December 31, 2020, the specific DSO value is not available (marked as "— days"), making it difficult to assess the efficiency of the company in collecting its accounts receivable during that period.

2. The DSO for December 31, 2021, was 75.79 days, indicating that, on average, it took the company about 75.79 days to collect its accounts receivable.

3. There is no data available for the DSO for December 31, 2022 (marked as "— days"), leaving a gap in the trend analysis for that year.

4. By December 31, 2023, the DSO increased to 84.37 days, signifying a longer collection period compared to the previous year.

5. The DSO further escalated to 145.35 days by December 31, 2024, suggesting a significant increase in the average number of days it took for the company to collect its accounts receivable.

Overall, the trend in DSO shows variability in the company's ability to efficiently collect receivables, as evidenced by fluctuations and an overall increase in the collection period over the years. This may indicate changes in customer payment behavior, credit policies, or the company's collection processes that merit further investigation and monitoring.